Abiopharma

🔍 SIMPSON CAMILLA V (Director)

Company: GRI Bio, Inc. (GRI)

Report Date: 2025-08-26

Detailed Transactions and Holdings:

• Acquired 5,994 shares of Stock Option (Right to Buy) at $1.41 per share (Derivative)
  Date: 2025-08-26 | Code: A | Expires: 2035-08-26 | equity_swap_involved: 0 | shares_owned_after: 5,994.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Options to purchase 4,044 shares vested in full upon the date of grant and options to purchase 1,950 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant.